Biotech | July 10, 2023
Biotech startups are crucial to India’s future economy, says Dr Jitendra Singh
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
With this, the number of marketing approvals for its oncology products across 75 countries has gone up to 503
The €70 million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing for biopharma customers, increasing annual output by several thousand tons
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Dignitaries and delegates commend India’s leadership in Global South during G20 India Presidency
Despite nearly 20 years of availability, biosimilars show worldwide adoption rate of only 14% in initiative-tracked countries, while reference medicines still represent 86% of biologic
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
Coverage of CGHS cities has expanded from 25 cities in 2014 to 80 in 2023
Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration
Subscribe To Our Newsletter & Stay Updated
